Literature DB >> 18840406

Establishment of a humanized model of liver using NOD/Shi-scid IL2Rgnull mice.

Hiroshi Suemizu1, Masami Hasegawa, Kenji Kawai, Kenji Taniguchi, Makoto Monnai, Masatoshi Wakui, Makoto Suematsu, Mamoru Ito, Gary Peltz, Masato Nakamura.   

Abstract

Severely immunodeficient NOD/Shi-scid IL2Rg(null) (NOG) mice are used as recipients for human tissue transplantation, which produces chimeric mice with various types of human tissue. NOG mice expressing transgenic urokinase-type plasminogen activator in the liver (uPA-NOG) were produced. Human hepatocytes injected into uPA-NOG mice repopulated the recipient livers with human cells. The uPA-NOG model has several advantages over previously produced chimeric mouse models of human liver: (1) the severely immunodeficient NOG background enables higher xenogeneic cell engraftment; (2) the absence of neonatal lethality enables mating of homozygotes, which increased the efficacy of homozygote production; and (3) donor xenogeneic human hepatocytes could be readily transplanted into young uPA-NOG mice, which provide easier surgical manipulation and improved recipient survival.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18840406     DOI: 10.1016/j.bbrc.2008.09.124

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  48 in total

1.  In vivo formation of dihydroxylated and glutathione conjugate metabolites derived from thalidomide and 5-Hydroxythalidomide in humanized TK-NOG mice.

Authors:  Hiroshi Yamazaki; Hiroshi Suemizu; Makiko Shimizu; Sho Igaya; Norio Shibata; Masato Nakamura; Goutam Chowdhury; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-01-25       Impact factor: 3.739

2.  New horizons for studying human hepatotropic infections.

Authors:  Ype P de Jong; Charles M Rice; Alexander Ploss
Journal:  J Clin Invest       Date:  2010-02-22       Impact factor: 14.808

3.  Higher Serum Alanine Transaminase Levels in Male Urokinase-Type Plasminogen Activator-Transgenic Mice Are Associated With Improved Engraftment of Hepatocytes but not Liver Sinusoidal Endothelial Cells.

Authors:  Marina E Fomin; Ashley I Beyer; Jean Publicover; Kai Lu; Sonia Bakkour; Graham Simmons; Marcus O Muench
Journal:  Cell Med       Date:  2016-11-23

4.  Human hepatocytes and hematolymphoid dual reconstitution in treosulfan-conditioned uPA-NOG mice.

Authors:  Tanuja L Gutti; Jaclyn S Knibbe; Edward Makarov; Jinjin Zhang; Govardhana R Yannam; Santhi Gorantla; Yimin Sun; David F Mercer; Hiroshi Suemizu; James L Wisecarver; Natalia A Osna; Tatiana K Bronich; Larisa Y Poluektova
Journal:  Am J Pathol       Date:  2013-11-06       Impact factor: 4.307

5.  A novel animal model for in vivo study of liver cancer metastasis.

Authors:  Shinsuke Fujiwara; Hikaru Fujioka; Chise Tateno; Ken Taniguchi; Masahiro Ito; Hiroshi Ohishi; Rie Utoh; Hiromi Ishibashi; Takashi Kanematsu; Katsutoshi Yoshizato
Journal:  World J Gastroenterol       Date:  2012-08-07       Impact factor: 5.742

6.  Human rotavirus-specific IgM Memory B cells have differential cloning efficiencies and switch capacities and play a role in antiviral immunity in vivo.

Authors:  Carlos F Narváez; Ningguo Feng; Camilo Vásquez; Adrish Sen; Juana Angel; Harry B Greenberg; Manuel A Franco
Journal:  J Virol       Date:  2012-08-01       Impact factor: 5.103

Review 7.  P450-Humanized and Human Liver Chimeric Mouse Models for Studying Xenobiotic Metabolism and Toxicity.

Authors:  Karl-Dimiter Bissig; Weiguo Han; Mercedes Barzi; Nataliia Kovalchuk; Liang Ding; Xiaoyu Fan; Francis P Pankowicz; Qing-Yu Zhang; Xinxin Ding
Journal:  Drug Metab Dispos       Date:  2018-08-09       Impact factor: 3.922

8.  The reconstituted 'humanized liver' in TK-NOG mice is mature and functional.

Authors:  Masami Hasegawa; Kenji Kawai; Tetsuya Mitsui; Kenji Taniguchi; Makoto Monnai; Masatoshi Wakui; Mamoru Ito; Makoto Suematsu; Gary Peltz; Masato Nakamura; Hiroshi Suemizu
Journal:  Biochem Biophys Res Commun       Date:  2011-01-14       Impact factor: 3.575

Review 9.  Assessing the therapeutic potential of lab-made hepatocytes.

Authors:  Milad Rezvani; Andrew A Grimm; Holger Willenbring
Journal:  Hepatology       Date:  2016-05-26       Impact factor: 17.425

10.  Can 'humanized' mice improve drug development in the 21st century?

Authors:  Gary Peltz
Journal:  Trends Pharmacol Sci       Date:  2013-04-19       Impact factor: 14.819

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.